ELV Elevance Health, Inc.

NYSE elevancehealth.com


$ 315.54 $ -4.75 (-1.48 %)    

Friday, 31-Oct-2025 19:07:56 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 317.2
$ 320.00
$ 315.00 x 43
$ 322.59 x 30
$ 314.03 - $ 320.77
$ 272.22 - $ 454.26
1,613,915
na
70.49B
$ 0.51
$ 12.74
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-21-2025 09-30-2025 10-Q
2 07-17-2025 06-30-2025 10-Q
3 04-22-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 10-17-2024 09-30-2024 10-Q
6 07-17-2024 06-30-2024 10-Q
7 04-18-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 10-18-2023 09-30-2023 10-Q
10 07-19-2023 06-30-2023 10-Q
11 04-19-2023 03-31-2023 10-Q
12 02-15-2023 12-31-2022 10-K
13 10-19-2022 09-30-2022 10-Q
14 07-20-2022 06-30-2022 10-Q
15 04-20-2022 03-31-2022 10-Q
16 02-16-2022 12-31-2021 10-K
17 10-20-2021 09-30-2021 10-Q
18 07-21-2021 06-30-2021 10-Q
19 04-21-2021 03-31-2021 10-Q
20 02-18-2021 12-31-2020 10-K
21 10-28-2020 09-30-2020 10-Q
22 07-29-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-19-2020 12-31-2019 10-K
25 10-23-2019 09-30-2019 10-Q
26 07-24-2019 06-30-2019 10-Q
27 04-24-2019 03-31-2019 10-Q
28 02-20-2019 12-31-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 07-25-2018 06-30-2018 10-Q
31 04-25-2018 03-31-2018 10-Q
32 02-21-2018 12-31-2017 10-K
33 10-25-2017 09-30-2017 10-Q
34 07-26-2017 06-30-2017 10-Q
35 04-26-2017 03-31-2017 10-Q
36 02-22-2017 12-31-2016 10-K
37 11-02-2016 09-30-2016 10-Q
38 07-27-2016 06-30-2016 10-Q
39 04-27-2016 03-31-2016 10-Q
40 02-19-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-elevance-health-raises-price-target-to-394

JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $384 to ...

 inflation-vs-reality-bilello-slams-clearly-wrong-government-data-claiming-health-insurance-prices-fell-18costs-only-go-in-one-direction

Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one dir...

 centene-and-oscar-health-stocks-sink-after-molina-warning

US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guida...

 td-cowen-maintains-buy-on-elevance-health-raises-price-target-to-380

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $330 to $380.

 wells-fargo-maintains-overweight-on-elevance-health-lowers-price-target-to-403

Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $...

 barclays-maintains-overweight-on-elevance-health-lowers-price-target-to-385

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $395 to ...

 elevance-healths-strong-quarter-cant-shake-off-medicaid-troubles

Elevance Health beats estimates, but shares fall due to Medicare pressures, Obamacare changes, and Medicaid attrition.

 gold-sinks-5-on-worst-day-in-5-years-dow-jones-hits-record-highs-whats-moving-markets-tuesday

Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, wh...

 elevance-health-exec-says-the-anticipated-expiration-of-enhanced-subsidies-would-significantly-impact-membership-in-2026-co-is-expanding-behavioral-health-interventions-strengthening-specialty-drug-management-co-is-planning-for-higher-costs-in-its-obamacare-plans-in-q4-as-members-utilize-their-benefits-ahead-of-coverage-changes-next-year-says-2026-will-be-the-low-point-in-medicaid-margins-with-improvement-expected-in-2027

- Conf Call

 elevance-health-raises-fy2025-gaap-eps-guidance-from-2410-to-2470-vs-2524-est

Elevance Health (NYSE:ELV) raises FY2025 GAAP EPS guidance from $24.10 to $24.70 vs $25.24 analyst estimate..

 elevance-health-affirms-fy2025-adj-eps-guidance-of-3000-vs-2990-est

Elevance Health (NYSE:ELV) affirms FY2025 Adj EPS guidance from $30.00 to $30.00 vs $29.90 analyst estimate..

 elevance-health-q3-adj-eps-603-beats-493-estimate-sales-50087b-beat-49369b-estimate

Elevance Health (NYSE:ELV) reported quarterly earnings of $6.03 per share which beat the analyst consensus estimate of $4.93 by...

 humana-loses-court-battle-over-medicare-advantage-ratings-billions-in-payments-at-risk

Texas court rules against Humana, upholding Medicare Advantage bonus cuts and risking billions in insurer revenue tied to star ...

 morgan-stanley-maintains-equal-weight-on-elevance-health-raises-price-target-to-359

Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from...

 goldman-sachs-initiates-coverage-on-elevance-health-with-neutral-rating-announces-price-target-of-343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health (NYSE:ELV) with a Neutral rating and announces Pric...

 b-of-a-securities-maintains-neutral-on-elevance-health-raises-price-target-to-370

B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target fr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION